Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GALE Antikörper

GALE Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2459745
  • Target Alle GALE Antikörper anzeigen
    GALE (UDP-Galactose-4-Epimerase (GALE))
    Reaktivität
    • 34
    • 20
    • 7
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 46
    • 3
    Kaninchen
    Klonalität
    • 48
    • 1
    Polyklonal
    Konjugat
    • 20
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser GALE Antikörper ist unkonjugiert
    Applikation
    • 38
    • 15
    • 13
    • 13
    • 5
    • 5
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Aufreinigung
    Antibody is purified by peptide affinity chromatography method.
    Immunogen
    Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human GALE.
    Top Product
    Discover our top product GALE Primärantikörper
  • Applikationshinweise
    GALE antibody can be used for detection of GALE by ELISA at 1:312500. GALE antibody can be used for detection of GALE by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.
    Konzentration
    1 mg/mL
    Buffer
    Antibody is lyophilized in PBS buffer with 2 % sucrose.
    Handhabung
    As with any antibody avoid repeat freeze-thaw cycles.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    For short periods of storage (days) store at 4 °C. For longer periods of storage, store GALE antibody at -20 °C.
  • Target
    GALE (UDP-Galactose-4-Epimerase (GALE))
    Andere Bezeichnung
    GALE (GALE Produkte)
    Synonyme
    GALE antikoerper, im:7147391 antikoerper, wu:fb05f01 antikoerper, zgc:136578 antikoerper, F15H21.11 antikoerper, F15H21_11 antikoerper, REB1 antikoerper, ROOT EPIDERMAL BULGER1 antikoerper, ROOT HAIR DEFECTIVE 1 antikoerper, UDP-GLUCOSE 4-EPIMERASE antikoerper, UGE4 antikoerper, ECK0748 antikoerper, galD antikoerper, JW0742 antikoerper, SMU.888 antikoerper, BA5505 antikoerper, BA5700 antikoerper, VFA0352 antikoerper, galE antikoerper, 2310002A12Rik antikoerper, AI323962 antikoerper, 1n569 antikoerper, xgale antikoerper, SDR1E1 antikoerper, UDP-galactose-4-epimerase antikoerper, NAD(P)-binding Rossmann-fold superfamily protein antikoerper, UDP-galactose 4-epimerase GalE antikoerper, UDP-glucose 4-epimerase antikoerper, UDP-glucose 4-epimerase GalE antikoerper, UDP-glucose/UDP-N-acetylglucosamine 4-epimerase antikoerper, galactose-4-epimerase, UDP antikoerper, UDP-galactose-4-epimerase L homeolog antikoerper, GALE antikoerper, gale antikoerper, RHD1 antikoerper, ECs0787 antikoerper, galE antikoerper, galE1 antikoerper, galE2 antikoerper, STY0809 antikoerper, galE-2 antikoerper, SG0897 antikoerper, galD antikoerper, Ent638_1250 antikoerper, Gale antikoerper, gale.L antikoerper
    Hintergrund
    GALE is an UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and mental retardation, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified.
    Molekulargewicht
    38 kDa
    Gen-ID
    2582
    NCBI Accession
    NP_001008217
    UniProt
    Q14376
    Pathways
    Response to Water Deprivation, Cellular Glucan Metabolic Process
Sie sind hier:
Kundenservice